ImmunoPrecise Antibodies Overview

ImmunoPrecise Antibodies Operating Income

Operating Income for IPA.

Quarterly Operating Income

$-3614166.00

↑ 9.75% YoY

As of Jan 31, 2026

Annual Operating Income (TTM)

$-12027947.00

↓ 14.09% YoY

Trailing 12 months ending Jan 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin